Ambu A/S (OTCMKTS:AMBBY) Sets New 1-Year Low – Should You Sell?

Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY)’s stock price reached a new 52-week low during mid-day trading on Friday . The stock traded as low as $9.5750 and last traded at $9.5750, with a volume of 3251 shares trading hands. The stock had previously closed at $9.7750.

Ambu A/S Stock Down 2.0%

The company has a market cap of $2.25 billion, a P/E ratio of 34.20 and a beta of 1.06. The company has a 50 day moving average of $10.61 and a 200-day moving average of $12.51. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.86 and a quick ratio of 1.67.

Ambu A/S (OTCMKTS:AMBBY) last posted its quarterly earnings data on Wednesday, May 6th. The company reported $0.07 earnings per share (EPS) for the quarter. The company had revenue of $246.39 million during the quarter. Ambu A/S had a return on equity of 8.13% and a net margin of 7.81%.

About Ambu A/S

Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company’s core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu’s offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.

Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.